Table:
begin	end	state
1	25	cytoplasmic
26	52	transmembrane
53	59	non-cytoplasmic
60	84	transmembrane
85	95	cytoplasmic
96	114	transmembrane
115	119	non-cytoplasmic
120	141	transmembrane
142	161	cytoplasmic
162	184	transmembrane
185	195	non-cytoplasmic
196	215	transmembrane
216	245	cytoplasmic
246	265	transmembrane
266	279	non-cytoplasmic
280	304	transmembrane
305	310	cytoplasmic
311	331	transmembrane
332	338	non-cytoplasmic
339	363	transmembrane
364	374	cytoplasmic
375	397	transmembrane
398	407	non-cytoplasmic
408	425	transmembrane
426	448	cytoplasmic

Input:
>AO353_15110
MPVQPLTRPDPARDTPTPGAGKKSIFAVVLGNAVEFFDFGVYATFAVMIGHTFFPSDSAF
VSLMLSVIAFGTGFIVRPLGAVLIGAYADRVGRKPAMLLTLVMMAVGTGSIAILPGYETI
GIAAPILLVVTRMIQGLAWGGEAGPATTYILEAAPPHKRGTYACWQVVAQGVAAMVAGLV
GFTLTKVLSPEDLNSWGWRVPFVFGLLVLPIGIYIRRNLAETFHGHTEQTRTGDLVREIV
GKHRRALVLGLLILSGSTITQYFLNYMTTFALTELKLPTSIAMLSTLVAGAAMAVCAVAG
GMLCDRFGRRVILMTPRVVLLLILFPALQLMTEHPSSATFLLTLAVLSGLHGMSGAALIV
LLVESFPKSVRATGFSIVYAFGVAAFGGTAQIIITWLIGTTGDPMSPVWYLLIANLVCLT
AAWFAKETRPLLPERPARETRLAEAQVH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server